Connection

James Stone to Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Back to Details
This is a "connection" page, showing publications James Stone has written about Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
James Stone
Connection Strength
1.157
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
  1. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Semin Arthritis Rheum. 2018 10; 48(2):288-292.
    View in: PubMed
    Score: 0.553
  2. The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis. J Autoimmun. 2019 12; 105:102302.
    View in: PubMed
    Score: 0.153
  3. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2018 07; 70(7):1114-1121.
    View in: PubMed
    Score: 0.141
  4. Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis. Rheumatology (Oxford). 2018 04 01; 57(4):639-650.
    View in: PubMed
    Score: 0.140
  5. The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis. Clin J Am Soc Nephrol. 2018 02 07; 13(2):251-257.
    View in: PubMed
    Score: 0.138
  6. Identification of Functional and Expression Polymorphisms Associated With Risk for Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Arthritis Rheumatol. 2017 05; 69(5):1054-1066.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.